Solid organ malignancy

1. Solid organ malignancy increases mortality in humans (24% (95% CI 17%-33%) at 10 years).

   “with a 10-year post-diagnosis survival rate of 24% (95% CI 17%-33%)”

   Humansafter solid organ malignancy diagnosis

   Solid Organ Malignancy After Pancreas Transplantation: A Four Decade Single-Center Experience

   Clinical transplantation·1 Dec 2025

1. Corticosteroids raise the risk of solid organ malignancy in humans (HR 1.51, 95% CI 1.00-2.27).

   “maintenance corticosteroid use (HR 1.51, 95% CI 1.00-2.27, p = 0.051)”

   Humanspost-transplant

   Solid Organ Malignancy After Pancreas Transplantation: A Four Decade Single-Center Experience

   Clinical transplantation·1 Dec 2025

More on Corticosteroids

1. Functioning graft status lowers the risk of solid organ malignancy in humans (HR 0.67, 95% CI 0.47-0.95).

   “Functioning graft status (HR 0.67, 95% CI 0.47-0.95, p = 0.024)”

   Humanspost-transplant

   Solid Organ Malignancy After Pancreas Transplantation: A Four Decade Single-Center Experience

   Clinical transplantation·1 Dec 2025